Talent recruitment services for office of therapeutic products (OTP) senior executive - to fill highly qualified and critical senior executive positions (office directors) to oversee the planning,…
Ended Awarded Last action
- Contract number
- 75F40123F19005
- Awardee
-
AE Strategies LLC UEI JLFXUUKV4BU3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $375,000
Award facts
- Contract value 100% obligated
- $375,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a BPA call to AE Strategies LLC on January 11, 2023, for talent recruitment services to fill senior executive positions in the Office of Therapeutic Products, with a ceiling value of $375,000 and an ultimate completion date of January 10, 2024. Work is performed in Silver Spring, Maryland. The call covers recruitment and staffing support for office directors overseeing planning, development, and direction of strategies and actions within the OTP. The parent vehicle is a Blanket Purchase Agreement with the FDA for executive recruitment services. AE Strategies is a for-profit limited liability company specializing in human capital and organizational improvement services for federal agencies, with prior FDA contract experience in executive recruitment.
Description
Talent recruitment services for office of therapeutic products (OTP) senior executive - to fill highly qualified and critical senior executive positions (office directors) to oversee the planning, development, and direction of strategies and actions
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Oxford University Press | $93,483 | |
| Exafluence Inc. | $543,000 | |
| Gartner, Inc. | $30,667 | |
| Conceptant Inc. | $588,328 | |
| Ntelx Inc. | $1,014,629 | |
| Chakrabarti Management Consultancy, Inc. | $896,754 | |
| Precise Software Solutions, Inc. | $1,216,639 | |
| Techsur Solutions LLC | $336,451 | |
| Scope It Consulting, LLC | $666,791 | |
| Infospan Global LLC | $2,167,302 | |
| Infospan Global LLC | $2,303,629 | |
| Istream Solutions, Inc. | $2,789,907 | |
| Rationalsoft Inc. | $778,844 | |
| Rationalsoft Inc. | $816,104 | |
| Sky Solutions LLC | $1,700,000 | |
| Agisol LLC | $670,715 |
Show all 16
Quick answers
Who was awarded contract 75F40123F19005?
75F40123F19005 was awarded to AE Strategies LLC by Food and Drug Administration (Department of Health and Human Services) on January 11, 2023.
How much is contract 75F40123F19005 worth?
The government has obligated $375,000 on 75F40123F19005.
Is contract 75F40123F19005 an order under another contract?
Yes. 75F40123F19005 is a BPA call under 47QTCA19D004S-75F40122A00006, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19005 competed?
The extent of competition for 75F40123F19005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award